Good to see a release of some information regarding what the company has been doing......and the move to a quarterly update...understand where they are heading...
it is a very factual, dry and almost dull document...I don't really get a feel either way whether the company is moving down the right path and whether based on results to date they will be successful moving this one forward into commercialisation....no clue as to whether the company is excited, pleased with results so far or otherwise...next 3 months will tell....will continue to hold but need to see some results...
They have 8.6m in bank and the burn rate is just over 4million p.a. based on last quarterly 4C
So Initial POC data pack to be completed in the next 3 months and then discussions commence with potential commercial partners begin... a more detailed POC pack with added clinical data to be ready second half of calendar 2017....by that time they will be looking at a Capital raise so they will need a strategic funding partner...
- Forums
- ASX - By Stock
- PYC
- Ann: Shareholder Update-PYC.AX
PYC
pyc therapeutics limited
Add to My Watchlist
0.40%
!
$1.27

Ann: Shareholder Update-PYC.AX, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M |
Open | High | Low | Value | Volume |
$1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | $1.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 1380 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | 1.265 |
2 | 16380 | 1.260 |
3 | 14380 | 1.255 |
3 | 103380 | 1.250 |
1 | 4000 | 1.225 |
Price($) | Vol. | No. |
---|---|---|
1.285 | 1380 | 1 |
1.290 | 27010 | 3 |
1.295 | 25880 | 2 |
1.300 | 59168 | 4 |
1.325 | 9001 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online